The Evolution of Injectable Medicines | Painted Clothes

Injectable medicines have been a cornerstone of modern healthcare since the early 20th century, with the first insulin injections in 1922 marking a significant milestone. Today, injectables account for over 50% of all new drug approvals, with a projected global market value of $1.4 trillion by 2027. However, concerns over safety, efficacy, and accessibility have sparked intense debates among patients, practitioners, and policymakers. The rise of biologics and biosimilars has further complicated the landscape, with companies like Pfizer, Merck, and Johnson & Johnson vying for market share. As the industry continues to evolve, questions remain about the long-term implications of injectable medicines on human health and the environment. With a Vibe score of 80, injectable medicines are a highly energized and contested topic, reflecting the complex interplay between medical innovation, economic interests, and societal needs.